- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Nautilus Biotechnology (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology (NASDAQ: NAUT)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-09 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.150 | -0.130 | 0.0200 | ||||
| REV | 170.000K | 0 | -170.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Nautilus Biotechnology Questions & Answers
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Quanterix (NASDAQ:QTRX), ChromaDex (NASDAQ:CDXC) and SomaLogic (NASDAQ:SLGC).
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Goldman Sachs on Wednesday, April 13, 2022. The analyst firm set a price target for 5.00 expecting NAUT to rise to within 12 months (a possible 87.27% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $2.67 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.